论文部分内容阅读
The role of nonclassical MHC class Ib-restricted CD8+ T cells in tumor immunity is largely elusive in mammalians.Mesenchymal stem cells (MSCs) are known to affect tumor growth and present antigens to T cells.Here we show that administration of C57BL/6 MSCs inhibited B16-F0 tumor growth in KbDb-/-mice (B6 background, MHC class Ia knockout) while not in wild-type C57BL/6 mice.Anti-tumor effect of MSCs could also be observed inKbDb-/-CIITA-/-mice but not in β2m-/-mice (whole MHC class I knockout) or CIITA-/-mice (MHC class Ⅱ knockout).Interestingly, CD8+ T cells were significantly increased in tumor as well as in the peripheral after MSC injection in KbDb-/-mice.